DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Mydayis is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are three patents protecting this drug and two Paragraph IV challenges.
This drug has thirty-three patent family members in thirty countries.
The generic ingredient in MYDAYIS is amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. There are fifty-five drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate profile page.
There have been fourteen patent litigation cases involving the patents protecting this drug, indicating strong interest in generic launch. Recent data indicate that 63% of patent challenges are decided in favor of the generic patent challenger and that 54% of successful patent challengers promptly launch generic drugs.
Indicators of Generic Entry
Summary for MYDAYIS
|Finished Product Suppliers / Packagers:||1|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for MYDAYIS|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for MYDAYIS|
|What excipients (inactive ingredients) are in MYDAYIS?||MYDAYIS excipients list|
|DailyMed Link:||MYDAYIS at DailyMed|
Recent Clinical Trials for MYDAYIS
Identify potential brand extensions & 505(b)(2) entrants
|Mayo Clinic||Phase 2|
|Lindner Center of HOPE||Phase 2|
|New York University School of Medicine||Phase 4|
Paragraph IV (Patent) Challenges for MYDAYIS
|MYDAYIS||CAPSULE, EXTENDED RELEASE;ORAL||amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate||022063||2017-08-07|
|MYDAYIS||CAPSULE, EXTENDED RELEASE;ORAL||amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate||022063||2017-08-03|
|Country||Patent Number||Estimated Expiration|
|Cyprus||1112335||Try Before You Buy|
|Mexico||PA05003129||Try Before You Buy|
|Spain||2360046||Try Before You Buy|
|Ecuador||SP055702||Try Before You Buy|
|Denmark||1542660||Try Before You Buy|
|>Country||>Patent Number||>Estimated Expiration|